Last reviewed · How we verify
NCT03138863: FETO
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)
NA trial testing BALT GoldbBAL2 Detachable Balloon in Congenital Diaphragmatic Hernia in 10 participants. Currently enrolling.
1 December 2027
Quick facts
| Lead sponsor | Rodrigo Ruano |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 May 2024 |
| Primary completion | 1 December 2027 |
| Estimated completion | 1 November 2030 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- BALT GoldbBAL2 Detachable Balloon
- Catheter System
Conditions studied
- Congenital Diaphragmatic Hernia — all drugs for Congenital Diaphragmatic Hernia →
- Pulmonary Hypoplasia — all drugs for Pulmonary Hypoplasia →
- Pulmonary Artery Hypertension — all drugs for Pulmonary Artery Hypertension →
Sponsor
Rodrigo Ruano
Who can join
Adults 18 to 50, female only, with Congenital Diaphragmatic Hernia or Pulmonary Hypoplasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to gather information on the safety and effectiveness of a new procedure called Fetoscopic Endoluminal Tracheal Occlusion (FETO).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03138863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Congenital Diaphragmatic Hernia
Currently open trials in the same condition.
- NCT05213676 — De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia · Phase 4 · recruiting
- NCT07187206 — Safety and Efficacy of FETO in CDH Phase III · Phase 3 · recruiting
- NCT07166172 — Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH · NA · recruiting
- NCT06739356 — North American Fetal Therapy Network for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe · NA · recruiting
- NCT06179472 — Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Conge · NA · active not recruiting
Other Rodrigo Ruano trials
Trials by the same sponsor.
- NCT03936322 — Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study · NA · completed
- NCT03281798 — Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03138863 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rodrigo Ruano
- Last refreshed: 23 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03138863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing